European Journal of Cancer
Volume 46, Issue 6 , Pages 1056-1061 , April 2010

Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis

Received 31 December 2009 ,Revised 1 February 2010 ,Accepted 5 February 2010.

References 

  1. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol. 2008;48(Suppl.):S20–S37
  2. Watanapa P, Watanapa WB. Liver fluke-associated cholangiocarcinoma. Br J Surg. 2002;89:962–970
  3. Hughes NR, Pairojkul C, Royce SG, Clouston A, Bhathal PS. Liver fluke-associated and sporadic cholangiocarcinoma: an immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. J Clin Pathol. 2006;59:1073–1078
  4. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case–control study. Hepatology. 2000;31:247–248
  5. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125
  6. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case–control study. Gastroenterology. 2005;128:620–626
  7. Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarinoma: a hospital-based case–control study. Am J Gastroenterol. 2007;102:1016–1021
  8. Ben-Menachem T. Risk factors for cholangiocarcinoma. Eur J Gastroenterol Hepatol. 2007;19(8):615–617
  9. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver dis. 2008;12:131–150
  10. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401
  11. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63:5821–5828
  12. Wilkens L, Bredt M, Flemming P, et al. Differentiation of multicentric origin from intra-organ metastatic spread of hepatocellular carcinomas by comparative genomic hybridization. J Pathol. 2000;192:43–51
  13. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308–321
  14. Lee CH, Chang CJ, Lin YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J cancer. 2009;100:1765–1770
  15. Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357:1974–1976
  16. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576
  17. Kuper H, Ye W, Broome U, et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology. 2001;34:714–718
  18. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans. Hepatology. 2009;49:116–123
  19. Gitlin D, Perricelli A, Gitlin GM. Synthesis of-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32:979–982
  20. Bruce MG, Bruden D, McMahon BJ, et al. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C. J Viral Hepat. 2008;15:179–187
  21. Murugavel KG, Mathews S, Jayanthi V, et al. Alpha-fetoprotein as a tumour marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Int J Infect Dis. 2008;12:e71–e76
  22. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983–3988
  23. Ishikawa K, Sasaki A, Haraguchi N, Yoshikawa Y, Mori M. A vase of an α-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin. Oncologist. 2007;12:320–324
  24. Dabeva MD, Shafritz DA. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am J Pathol. 1993;143:1606–1620
  25. Shiojiri N, Lemire JM, Fausto N. Cell lineage and oval cell progenitors in rat liver development. Cancer Res. 1991;51:2611–2620
  26. Shirabe K, Shimada M, Harimoto N, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery. 2002;131:S159–S164

PII: S0959-8049(10)00108-5

doi: 10.1016/j.ejca.2010.02.005

European Journal of Cancer
Volume 46, Issue 6 , Pages 1056-1061 , April 2010

Article Tools

* Image Usage & Resolution